SLC38A9 is directly involved in Tat-induced endolysosome dysfunction and senescence in astrocytes
Life Science Alliance · 2025-07 · 8 (7) · e202503231
DOI: 10.26508/lsa.202503231 ↗Kurz gefasst
Fachartikel in der Zeitschrift Life Science Alliance, online erschienen am 05.05.2025. Verfasst von Neda Rezagholizadeh und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biomedical Sciences, University of North Dakota School of Medicine and Health Sciences, Grand Forks, ND, USA. Hauptthemen laut MEDLINE: Astrocytes, Cellular Senescence, Lysosomes, tat Gene Products, Human Immunodeficiency Virus. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 144 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIDA NIH HHS, NIMH NIH HHS, HHS | NIH | National Institute of Mental Health.
Abstract (Originalsprache)
Cellular senescence contributes to accelerated aging and the development of various neurodegeneration disorders including HIV-associated neurocognitive disorders. The development of HIV-associated neurocognitive disorders is attributed, at least in part, to the CNS persistence of HIV-1 transactivator of transcription (Tat), an essential protein for viral transcription that is actively secreted from HIV-1–infected cells. Secreted Tat enters cells via receptor-mediated endocytosis and induces endolysosome dysfunction and cellular senescence in CNS cells. Given that endolysosome dysfunction represents an early step in exogenous Tat-induced cellular senescence, we tested the hypothesis that Tat induces cellular senescence via an endolysosome-dependent mechanism in human astrocytes. We demonstrated that internalized Tat interacts with an endolysosome-resident arginine sensor SLC38A9 via the arginine-rich basic domain. Such an interaction between Tat and SLC38A9 leads to endolysosome dysfunction, enhanced HIV-1 LTR transactivation, and cellular senescence. These findings suggest that endolysosome dysfunction drives the development of senescence and highlight the novel role of SLC38A9 in Tat-induced endolysosome dysfunction and astrocyte senescence.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Biomedical Sciences, University of North Dakota School of Medicine and Health Sciences, Grand Forks, ND, USA.
- Department of Biomedical Sciences, University of North Dakota School of Medicine and Health Sciences, Grand Forks, ND, USA xuesong.chen@und.edu.
ORCID-Profile: Xuesong Chen
Förderung
- NIDA NIH HHS
- NIMH NIH HHS
- HHS | NIH | National Institute of Mental Health
- HHS | NIH | National Institute on Drug Abuse
Zitieren
APA
Rezagholizadeh, N., Datta, G., Hasler, W. A., Nguon, E. C., Smokey, E. V., Khan, N., & Chen, X. (2025). SLC38A9 is directly involved in Tat-induced endolysosome dysfunction and senescence in astrocytes. Life Science Alliance, 8(7), e202503231. https://doi.org/10.26508/lsa.202503231
Vancouver
Rezagholizadeh N, Datta G, Hasler WA, Nguon EC, Smokey EV, Khan N, et al. SLC38A9 is directly involved in Tat-induced endolysosome dysfunction and senescence in astrocytes. Life Science Alliance. 2025;8(7):e202503231. doi:10.26508/lsa.202503231
BibTeX
@article{Rezagholizadeh2025,
author = {Rezagholizadeh, Neda and Datta, Gaurav and Hasler, Wendie A and Nguon, Erica C and Smokey, Elise V and Khan, Nabab and Chen, Xuesong},
title = {SLC38A9 is directly involved in Tat-induced endolysosome dysfunction and senescence in astrocytes},
journal = {Life Science Alliance},
year = {2025},
volume = {8},
number = {7},
pages = {e202503231},
doi = {10.26508/lsa.202503231}
}
EUVIMED